Beam Therapeutics Inc. Contracts & Agreements
60 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (4)
- Human Resources (17)
- Intellectual Property (9)
- Mergers & Acquisitions (1)
- Real Estate (5)
- Uncategorized (9)
- Amendment to License Agreement between The Broad Institute, Inc. and Beam Therapeutics Inc., dated May 31, 2024 (Filed With SEC on August 6, 2024)
- Form of Addendum to Letter Agreement between Beam Therapeutics Inc. and each of its executive officers (Filed With SEC on May 7, 2024)
- Amended and Restated Beam Therapeutics Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 7, 2024)
- Third Amendment to Lease, between Beam Therapeutics Inc. and ARE-NC Region No.14, LLC, dated January 1, 2024 (Filed With SEC on February 27, 2024)
- Second Amendment to Lease, between Beam Therapeutics Inc. and ARE-NC Region No. 14, LLC, dated March 31, 2023 (Filed With SEC on February 27, 2024)
- First Amendment to Lease, between Beam Therapeutics Inc. and ARE-NC Region No. 14, LLC, dated June 23, 2022 (Filed With SEC on February 27, 2024)
- Amended and Restated Beam Therapeutics Inc. Non-Employee Director Compensation Policy, dated January 22, 2024 (Filed With SEC on February 27, 2024)
- Amendment No. 2 to Sales Agreement, dated May 10, 2023, by and between Beam Therapeutics Inc. and Jefferies LLC (Filed With SEC on May 10, 2023)
- Amended and Restated Non-employee Director Compensation Policy (Filed With SEC on May 9, 2022)
- Amendment No. 3 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated August 24, 2021 (Filed With SEC on February 28, 2022)
- Amendment No. 2 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated November 17, 2020 (Filed With SEC on February 28, 2022)
- Amendment No. 1 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated April 14, 2020 (Filed With SEC on February 28, 2022)
- Amended and Restated Beam Therapeutics Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on February 28, 2022)
- Amended and Restated Letter Agreement between Beam Therapeutics Inc. and John Evans dated June 9, 2021 (Filed With SEC on August 10, 2021)
- Amended and Restated Beam Therapeutics Inc. Non-Employee Director Compensation Policy dated June 10, 2021 (Filed With SEC on August 10, 2021)
- Amendment No. 1 to Sales Agreement, dated July 7, 2021, by and between Beam Therapeutics Inc. and Jefferies LLC (Filed With SEC on July 7, 2021)
- Sales Agreement, dated April 1, 2021, by and between Beam Therapeutics Inc. and Jefferies LLC (Filed With SEC on April 1, 2021)
- Beam Therapeutics Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 15, 2021)
- Form of Restricted Stock Award Agreement under the Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on March 15, 2021)
- Form of Restricted Stock Unit Award Agreement under the Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on March 15, 2021)
- Letter Agreement, between the President and Fellows of Harvard College, The Broad Institute, Inc., and Beam Therapeutics Inc., dated January 7, 2021 (Filed With SEC on March 15, 2021)
- Letter Agreement, between Beam Therapeutics Inc., The Broad Institute, Inc., the President and Fellows of Harvard College, and Editas Medicine, Inc., dated September 26, 2018 (Filed With SEC on March 15, 2021)
- First Amendment to License Agreement, between The Broad Institute, Inc. and Blink Therapeutics Inc., dated September 4, 2018 (Filed With SEC on March 15, 2021)
- Amendment No. 2 to License Agreement, between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated March 27, 2020 (Filed With SEC on March 15, 2021)
- Amendment No. 1 to License Agreement, between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated December 12, 2017 (Filed With SEC on March 15, 2021)
- Agreement and Plan of Merger, dated February 22, 2021, among Beam Therapeutics Inc., Galileo Merger Sub I, Inc., Galileo Merger Sub II, LLC, Guide Therapeutics, Inc. (Guide),... (Filed With SEC on March 15, 2021)
- Form of Purchase Agreement, dated as of January 16, 2021, among Beam Therapeutics Inc. and each purchaser party thereto (Filed With SEC on January 19, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 28, 2020)
- Lease Agreement between Beam Therapeutics Inc. and ARE-NC Region No. 14, LLC (Filed With SEC on August 12, 2020)
- Description of Registered Securities (Filed With SEC on March 30, 2020)
- Letter Agreement between Beam Therapeutics Inc. and John Evans, dated January 24, 2020 (Filed With SEC on January 27, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 27, 2020)
- Beam Therapeutics Inc. Non-Employee Director Compensation Policy (Filed With SEC on January 27, 2020)
- Beam Therapeutics Inc. 2019 Cash Incentive Plan (Filed With SEC on January 27, 2020)
- Beam Therapeutics Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on January 27, 2020)
- Form of Non-Statutory Stock Option Agreement (Non-Employee Directors) under the Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on January 27, 2020)
- Form of Non-Statutory Stock Option Agreement under the Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on January 27, 2020)
- Form of Incentive Stock Option Agreement under the Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on January 27, 2020)
- Beam Therapeutics Inc. 2019 Equity Incentive Plan (Filed With SEC on January 27, 2020)
- Letter Agreement between Beam Therapeutics Inc. and Terry-Ann Burrell, dated January 24, 2020 (Filed With SEC on January 27, 2020)
- Amended and Restated Employment Agreement between Beam Therapeutics Inc. and Giuseppe Ciaramella, dated January 24, 2020 (Filed With SEC on January 27, 2020)
- Beam Therapeutics Inc. 2017 Stock Option and Grant Plan (Filed With SEC on January 27, 2020)
- Employment Agreement between Beam Therapeutics Inc. and Terry-Ann Burrell, dated September 25, 2019 (Filed With SEC on January 17, 2020)
- License Agreement, by and between The Broad Institute, Inc. and Blink Therapeutics Inc., dated as of May 9, 2018 (Filed With SEC on September 27, 2019)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on September 27, 2019)
- Indenture of Lease, by and between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated as of April 24, 2019 (Filed With SEC on September 27, 2019)
- Lease, by and between UP 26 Landsdowne, LLC and Beam Therapeutics Inc., dated February 21, 2018 (Filed With SEC on September 27, 2019)
- Letter Agreement between Beam Therapeutics Inc. and Courtney Wallace, dated September 25, 2019 (Filed With SEC on September 27, 2019)
- Amended and Restated Employment Agreement between Beam Therapeutics Inc. and Giuseppe Ciaramella, dated September 25, 2019 (Filed With SEC on September 27, 2019)
- Letter Agreement between Beam Therapeutics Inc. and John Evans, dated September 25, 2019 (Filed With SEC on September 27, 2019)
- Form of Indemnification Agreement between Beam Therapeutics Inc. and its directors and officers (Filed With SEC on September 27, 2019)
- Form of Non-Qualified Stock Option Grant Notice under the Beam Therapeutics Inc. 2017 Stock Option and Grant Plan (Filed With SEC on September 27, 2019)
- Form of Incentive Stock Option Grant Notice under the Beam Therapeutics Inc. 2017 Stock Option and Grant Plan (Filed With SEC on September 27, 2019)
- Form of Restricted Stock Agreement under the Beam Therapeutics Inc. 2017 Stock Option and Grant Plan (Filed With SEC on September 27, 2019)
- Beam Therapeutics Inc. 2017 Stock Option and Grant Plan (Filed With SEC on September 27, 2019)
- License Agreement, by and between Bio Palette Co., Ltd. and Beam Therapeutics Inc., dated as of March 27, 2019 (Filed With SEC on September 27, 2019)
- License Agreement, by and between Editas Medicine, Inc. and Beam Therapeutics Inc., dated as of May 9, 2018 (Filed With SEC on September 27, 2019)
- License Agreement, by and between the President and Fellows of Harvard College and Beam Therapeutics Inc., dated as of June 27, 2017 (Filed With SEC on September 27, 2019)
- License Agreement, by and between MIL 21E, LLC and Beam Therapeutics Inc., dated as of June 25, 2019 (Filed With SEC on September 27, 2019)
- Amended and Restated Investors Rights Agreement, by and among Beam Therapeutics Inc. and the investors party thereto, dated as of November 8, 2018 (Filed With SEC on September 27, 2019)
